Headlines

BioMedNewsBreaks

BioMedNewsBreaks — Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Reports FY 2025 Net Income of $249 Million 
Oncotelic Therapeutics, Inc. (OTLC)
April 16, 2026
BioMedNewsBreaks — Earth Science Tech Inc. (ETST) Advancing Multi-Platform Healthcare Strategy
Earth Science Tech Inc. (ETST)
April 15, 2026
BioMedNewsBreaks — Polyrizon Ltd. (NASDAQ: PLRZ) Closes $3.5 Million Registered Direct Offering and Concurrent Private Placement 
Polyrizon Ltd. (PLRZ)
April 15, 2026
BioMedNewsBreaks — MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Engages Venture Liquidity Providers for Market-Making Services 
MindBio Therapeutics Corp. (MBQIF)
April 15, 2026
BioMedNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Forms NRx Defense Systems Subsidiary to Advance Neuroplastic Therapies for Military and Government Applications
NRx Pharmaceuticals, Inc. (NRXP)
April 15, 2026
View More BioMedNewsBreaks

BioMedWire Articles

Soligenix Inc. (NASDAQ: SNGX) Advances CTCL Research with Interim Analysis, Comparative Study Results
Soligenix Inc. (SNGX)
April 16, 2026
New AI Tool Could Boost the Early Detection of Lung Cancer
Calidi Biotherapeutics Inc. (CLDI)
April 16, 2026
Oncotelic Therapeutics Inc. (OTLC) Expands Beyond Biotech Through AI-Robotics Pivot, Unlocking New Value in GMP Automation
Oncotelic Therapeutics Inc. (OTLC)
April 16, 2026
Compact Proton Therapy Delivery Helps Make the Treatment More Accessible for Cancer Patients
Lixte Biotechnology Holdings, Inc. (LIXT)
April 15, 2026
Soligenix Inc. (NASDAQ: SNGX) Gains Analytical Validation as Pipeline Progress Drives Forward Outlook
Soligenix Inc. (SNGX)
April 15, 2026
View All BioMedWire Articles

Public Press Releases

Filter Releases
Filters
Sector



Remove All Filters
Symbol Release Time Source
{{ release.qmtopics.qmsymbol[0].symbol }} {{ release.headline }} {{ release.datetime | amDateFormat:'hh:mm A'}} {{ release.source }}
Load More

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000

BioMedWire
BioMedWire

1108 Lavaca St
Suite 110-BMW
Austin, TX 78701
(512) 354-7000

Company Search
Get Quote
Site Search

Copyright © . BioMedWire / 1108 Lavaca St Suite 110-BMW Austin, TX 78701 (512) 354-7000 / Disclaimers